Injection/Infusion
ABEVMY CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/4ML
Summary
ABEVMY CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/4ML — Injection/Infusion containing bevacizumab. Hong Kong Registration No. HK-69197. Certificate Holder: PRIMEDICA LIMITED. Date of Registration: 25 Aug, 2026.
Product NameABEVMY CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/4ML
Registration No.HK-69197
Certificate HolderPRIMEDICA LIMITED
Holder AddressUNIT A, 4/F, RAINBOW FACTORY BLDG, 149 WAI YIP ST, KWUN TONG, KOWLOON
Ingredientsbevacizumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration25 Aug, 2026
ATC codesL01FG01, S01LA08
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents / S Sensory Organs
All ATC groupsL01, S01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。